Roel Docter

899 total citations
17 papers, 798 citations indexed

About

Roel Docter is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Roel Docter has authored 17 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Roel Docter's work include Thyroid Disorders and Treatments (9 papers), Amino Acid Enzymes and Metabolism (3 papers) and Nitric Oxide and Endothelin Effects (3 papers). Roel Docter is often cited by papers focused on Thyroid Disorders and Treatments (9 papers), Amino Acid Enzymes and Metabolism (3 papers) and Nitric Oxide and Endothelin Effects (3 papers). Roel Docter collaborates with scholars based in Netherlands, Switzerland and Australia. Roel Docter's co-authors include Theo J. Visser, G Hennemann, Eric P. Krenning, Bert F. Bernard, Edith C. H. Friesema, François Verrey, E P Moerings, Durk Fekkes, Jan A. Mol and G. Hennemann and has published in prestigious journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Roel Docter

17 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roel Docter Netherlands 13 484 294 111 102 90 17 798
Jacob G. Ghazarian United States 14 388 0.8× 227 0.8× 36 0.3× 166 1.6× 218 2.4× 36 1.0k
Isadore N. Rosenberg United States 13 488 1.0× 383 1.3× 56 0.5× 46 0.5× 204 2.3× 27 783
William Grogan United States 20 213 0.4× 354 1.2× 241 2.2× 60 0.6× 75 0.8× 62 983
Susumu Kodama Japan 19 329 0.7× 403 1.4× 78 0.7× 256 2.5× 110 1.2× 34 1.1k
Arthur I. Salhanick United States 15 246 0.5× 292 1.0× 102 0.9× 59 0.6× 137 1.5× 21 708
Åke Stenbeŕg Sweden 15 554 1.1× 155 0.5× 45 0.4× 176 1.7× 85 0.9× 34 891
C H Shackleton United States 11 288 0.6× 164 0.6× 25 0.2× 80 0.8× 63 0.7× 12 541
Karmela Schneidman United States 10 157 0.3× 134 0.5× 77 0.7× 84 0.8× 78 0.9× 13 584
Øystein Spydevold Norway 20 115 0.2× 716 2.4× 205 1.8× 62 0.6× 346 3.8× 38 1.3k
R.M.E. Vos Netherlands 16 93 0.2× 423 1.4× 63 0.6× 103 1.0× 23 0.3× 30 830

Countries citing papers authored by Roel Docter

Since Specialization
Citations

This map shows the geographic impact of Roel Docter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roel Docter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roel Docter more than expected).

Fields of papers citing papers by Roel Docter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roel Docter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roel Docter. The network helps show where Roel Docter may publish in the future.

Co-authorship network of co-authors of Roel Docter

This figure shows the co-authorship network connecting the top 25 collaborators of Roel Docter. A scholar is included among the top collaborators of Roel Docter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roel Docter. Roel Docter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Peeters, Robin P., Edith C. H. Friesema, Roel Docter, G Hennemann, & Theo J. Visser. (2002). Effects of thyroid state on the expression of hepatic thyroid hormone transporters in rats. American Journal of Physiology-Endocrinology and Metabolism. 283(6). E1232–E1238. 7 indexed citations
2.
Friesema, Edith C. H., Roel Docter, E P Moerings, et al.. (2001). Thyroid Hormone Transport by the Heterodimeric Human System L Amino Acid Transporter. Endocrinology. 142(10). 4339–4348. 148 indexed citations
3.
Lim, Chen‐Fee, Roel Docter, Eric P. Krenning, et al.. (1994). Transport of thyroxine into cultured hepatocytes: effects of mild non‐thyroidal illness and calorie restriction in obese subjects. Clinical Endocrinology. 40(1). 79–85. 27 indexed citations
4.
5.
Langsteger, Werner, et al.. (1994). Familial dysalbuminaemic hyperthyroxinaemia and inherited partial TBG deficiency: first report. Clinical Endocrinology. 40(6). 751–758. 6 indexed citations
6.
Docter, Roel, et al.. (1993). Reduced T3 deiodination by the human hepatoblastoma cell line HepG2 caused by deficient T3 sulfation. Biochimica et Biophysica Acta (BBA) - General Subjects. 1157(1). 114–118. 7 indexed citations
7.
Jong, Marion de, Roel Docter, Eric P. Krenning, et al.. (1991). Thyroxine and 3,3′,5-Triiodothyronine Are Glucuronidated in Rat Liver by Different Uridine Diphosphate-Glucuronyltransferases*. Endocrinology. 128(2). 741–746. 113 indexed citations
8.
Docter, Roel. (1991). Role of cellular transport systems in the regulation of thyroid hormone bioavailability. RePub (Erasmus University, Rotterdam). 15 indexed citations
9.
10.
Mol, Jan A., et al.. (1984). Inactivation and affinity-labeling of rat liver iodothyronine deiodinase with N-bromoacetyl-3,3′,5-triiodothyronine. Biochemical and Biophysical Research Communications. 124(2). 475–483. 46 indexed citations
11.
Klijn, Jan G.M., Frank H. de Jong, Marinus A. Blankenstein, et al.. (1984). Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer. Breast Cancer Research and Treatment. 4(3). 209–220. 33 indexed citations
12.
Mol, Jan A., Roel Docter, G. Hennemann, & Theo J. Visser. (1984). Modification of rat liver iodothyronine 5′-deiodinase activity with diethylpyrocarbonate and Rose Bengal; Evidence for an active site histidine residue. Biochemical and Biophysical Research Communications. 120(1). 28–36. 38 indexed citations
13.
Krenning, Eric P., Roel Docter, Bert F. Bernard, Theo J. Visser, & G Hennemann. (1982). Decreased transport of thyroxine (T4), 3,3′‐5‐triiodothyronine (T3) and 3,3′,5′‐triiodothyronine (rT3) into rat hepatocytes in primary culture due to a decrease of cellular ATP content and various drugs. FEBS Letters. 140(2). 229–233. 86 indexed citations
14.
Krenning, Eric P., Roel Docter, Bert F. Bernard, Theo J. Visser, & G Hennemann. (1980). Regulation of the active transport of 3,3′,5‐triiodothyronine (T3) into primary cultured rat hepatocytes by ATP. FEBS Letters. 119(2). 279–282. 26 indexed citations
15.
Visser, Theo J., et al.. (1979). Inhibition of iodothyronine 5′‐deiodinase by thioureylenes; Structure‐activity relationship. FEBS Letters. 103(2). 314–318. 46 indexed citations
16.
Fekkes, Durk, et al.. (1979). Location of rat liver iodothyronine deiodinating enzymes in the endoplasmic reticulum. Biochimica et Biophysica Acta (BBA) - General Subjects. 587(1). 12–19. 43 indexed citations
17.
Visser, Theo J., et al.. (1975). Conversion of thyroxine into tri-iodothyronine by rat liver homogenate. Biochemical Journal. 150(3). 489–493. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacob G. Ghazarian Breakdown of academic impact, for papers by Isadore N. Rosenberg Breakdown of academic impact, for papers by William Grogan Breakdown of academic impact, for papers by Susumu Kodama Breakdown of academic impact, for papers by Arthur I. Salhanick Breakdown of academic impact, for papers by Åke Stenbeŕg Breakdown of academic impact, for papers by C H Shackleton Breakdown of academic impact, for papers by Karmela Schneidman Breakdown of academic impact, for papers by Øystein Spydevold Breakdown of academic impact, for papers by R.M.E. Vos
Rankless by CCL
2026